Journal
MEDICAL CARE
Volume 55, Issue 6, Pages 552-560Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MLR.0000000000000719
Keywords
hypertension; antihypertensive medication; cost-effectiveness; disparities; cardiovascular disease
Categories
Funding
- National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01 NS041588]
- NIH/NHLBI [5T32 HL00745733]
Ask authors/readers for more resources
Background:Antihypertensive medication decreases risk of cardiovascular disease (CVD) events in adults with hypertension. Although black adults have higher prevalence of hypertension and worse CVD outcomes compared with whites, limited attention has been given to the cost-effectiveness of antihypertensive medication for blacks.Objective:To compare the cost-effectiveness of antihypertensive medication treatment versus no-treatment in white and black adults.Research Design:We constructed a State Transition Model to assess the costs and quality-adjusted life-years (QALYs) associated with either antihypertensive medication treatment or no-treatment using data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study and published literature. CVD events and health states considered in the model included stroke, coronary heart disease, heart failure, chronic kidney disease, and end-stage renal disease.Subjects:White and black adults with hypertension in the United States, 45 years of age and above.Measures:Yearly risk of CVD was determined using REGARDS data and published literature. Antihypertensive medication costs were determined using Medicare claims. Event and health state costs were estimated from published literature. All costs were adjusted to 2012 US dollars. Effectiveness was assessed using QALYs.Results:Antihypertensive medication treatment was cost-saving and increased QALYs compared with no-treatment for white men ($7387; 1.14 QALYs), white women ($7796; 0.89 QALYs), black men ($8400; 1.66 QALYs), and black women ($10,249; 1.79 QALYs).Conclusions:Antihypertensive medication treatment is cost-saving and increases QALYs for all groups considered in the model, particularly among black adults.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available